Cargando…

The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer

BACKGROUND: Data examining associations among social support, survival, and healthcare utilization are lacking in patients with advanced cancer. METHODS: We conducted a cross-sectional secondary analysis using data from a prospective longitudinal cohort study of 966 hospitalized patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Sunil, Johnson, P Connor, Markovitz, Netana H, Gray, Tamryn, Nipp, Ryan D, Ufere, Nneka, Rice, Julia, Reynolds, Matthew J, Lavoie, Mitchell W, Clay, Madison A, Lindvall, Charlotta, El-Jawahri, Areej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907037/
https://www.ncbi.nlm.nih.gov/pubmed/36427022
http://dx.doi.org/10.1093/oncolo/oyac238
_version_ 1784884090189643776
author Bhatt, Sunil
Johnson, P Connor
Markovitz, Netana H
Gray, Tamryn
Nipp, Ryan D
Ufere, Nneka
Rice, Julia
Reynolds, Matthew J
Lavoie, Mitchell W
Clay, Madison A
Lindvall, Charlotta
El-Jawahri, Areej
author_facet Bhatt, Sunil
Johnson, P Connor
Markovitz, Netana H
Gray, Tamryn
Nipp, Ryan D
Ufere, Nneka
Rice, Julia
Reynolds, Matthew J
Lavoie, Mitchell W
Clay, Madison A
Lindvall, Charlotta
El-Jawahri, Areej
author_sort Bhatt, Sunil
collection PubMed
description BACKGROUND: Data examining associations among social support, survival, and healthcare utilization are lacking in patients with advanced cancer. METHODS: We conducted a cross-sectional secondary analysis using data from a prospective longitudinal cohort study of 966 hospitalized patients with advanced cancer at Massachusetts General Hospital from 2014 through 2017. We used NLP to identify extent of patients’ social support (limited versus adequate as defined by NLP-aided review of the Electronic Health Record (EHR)). Two independent coders achieved a Kappa of 0.90 (95% CI: 0.84-1.00) using NLP. Using multivariable regression models, we examined associations of social support with: 1) OS; 2) death or readmission within 90 days of hospital discharge; 3) time to readmission within 90 days; and 4) hospital length of stay (LOS). RESULTS: Patients’ median age was 65 (range: 21-92) years, and a plurality had gastrointestinal (GI) cancer (34.3%) followed by lung cancer (19.5%). 6.2% (60/966) of patients had limited social support. In multivariable analyses, limited social support was not significantly associated with OS (HR = 1.13, P = 0.390), death or readmission (OR = 1.18, P = 0.578), time to readmission (HR = 0.92, P = 0.698), or LOS (β = −0.22, P = 0.726). We identified a potential interaction suggesting cancer type (GI cancer versus other) may be an effect modifier of the relationship between social support and OS (interaction term P = 0.053). In separate unadjusted analyses, limited social support was associated with lower OS (HR = 2.10, P = 0.008) in patients with GI cancer but not other cancer types (HR = 1.00, P = 0.991). CONCLUSION: We used NLP to assess the extent of social support in patients with advanced cancer. We did not identify significant associations of social support with OS or healthcare utilization but found cancer type may be an effect modifier of the relationship between social support and OS. These findings underscore the potential utility of NLP for evaluating social support in patients with advanced cancer.
format Online
Article
Text
id pubmed-9907037
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99070372023-02-09 The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer Bhatt, Sunil Johnson, P Connor Markovitz, Netana H Gray, Tamryn Nipp, Ryan D Ufere, Nneka Rice, Julia Reynolds, Matthew J Lavoie, Mitchell W Clay, Madison A Lindvall, Charlotta El-Jawahri, Areej Oncologist Health Outcomes and Economics of Cancer Care BACKGROUND: Data examining associations among social support, survival, and healthcare utilization are lacking in patients with advanced cancer. METHODS: We conducted a cross-sectional secondary analysis using data from a prospective longitudinal cohort study of 966 hospitalized patients with advanced cancer at Massachusetts General Hospital from 2014 through 2017. We used NLP to identify extent of patients’ social support (limited versus adequate as defined by NLP-aided review of the Electronic Health Record (EHR)). Two independent coders achieved a Kappa of 0.90 (95% CI: 0.84-1.00) using NLP. Using multivariable regression models, we examined associations of social support with: 1) OS; 2) death or readmission within 90 days of hospital discharge; 3) time to readmission within 90 days; and 4) hospital length of stay (LOS). RESULTS: Patients’ median age was 65 (range: 21-92) years, and a plurality had gastrointestinal (GI) cancer (34.3%) followed by lung cancer (19.5%). 6.2% (60/966) of patients had limited social support. In multivariable analyses, limited social support was not significantly associated with OS (HR = 1.13, P = 0.390), death or readmission (OR = 1.18, P = 0.578), time to readmission (HR = 0.92, P = 0.698), or LOS (β = −0.22, P = 0.726). We identified a potential interaction suggesting cancer type (GI cancer versus other) may be an effect modifier of the relationship between social support and OS (interaction term P = 0.053). In separate unadjusted analyses, limited social support was associated with lower OS (HR = 2.10, P = 0.008) in patients with GI cancer but not other cancer types (HR = 1.00, P = 0.991). CONCLUSION: We used NLP to assess the extent of social support in patients with advanced cancer. We did not identify significant associations of social support with OS or healthcare utilization but found cancer type may be an effect modifier of the relationship between social support and OS. These findings underscore the potential utility of NLP for evaluating social support in patients with advanced cancer. Oxford University Press 2022-11-25 /pmc/articles/PMC9907037/ /pubmed/36427022 http://dx.doi.org/10.1093/oncolo/oyac238 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Health Outcomes and Economics of Cancer Care
Bhatt, Sunil
Johnson, P Connor
Markovitz, Netana H
Gray, Tamryn
Nipp, Ryan D
Ufere, Nneka
Rice, Julia
Reynolds, Matthew J
Lavoie, Mitchell W
Clay, Madison A
Lindvall, Charlotta
El-Jawahri, Areej
The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title_full The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title_fullStr The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title_full_unstemmed The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title_short The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer
title_sort use of natural language processing to assess social support in patients with advanced cancer
topic Health Outcomes and Economics of Cancer Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907037/
https://www.ncbi.nlm.nih.gov/pubmed/36427022
http://dx.doi.org/10.1093/oncolo/oyac238
work_keys_str_mv AT bhattsunil theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT johnsonpconnor theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT markovitznetanah theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT graytamryn theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT nippryand theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT uferenneka theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT ricejulia theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT reynoldsmatthewj theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT lavoiemitchellw theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT claymadisona theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT lindvallcharlotta theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT eljawahriareej theuseofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT bhattsunil useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT johnsonpconnor useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT markovitznetanah useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT graytamryn useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT nippryand useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT uferenneka useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT ricejulia useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT reynoldsmatthewj useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT lavoiemitchellw useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT claymadisona useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT lindvallcharlotta useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer
AT eljawahriareej useofnaturallanguageprocessingtoassesssocialsupportinpatientswithadvancedcancer